Completed PHASE3 INTERVENTIONAL 3-arm NCT00655174

Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood?

A Double-Blind Placebo-Controlled Randomized Clinical Trial of Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood?

Sponsor: The Hospital for Sick Children

Conditions Autism

Interventions Placebo fluvoxamine sertraline

Updated 4 times since 2017 Last updated: Apr 4, 2008 Started: Jun 30, 1999 Primary completion: Sep 30, 2006 Completion: Jan 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Autism, this trial is completed. The trial is conducted by The Hospital for Sick Children and has accumulated 4 data snapshots since 1999. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2017 — Jan 2021 [monthly]

Completed PHASE3

First recorded

Jun 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Hospital for Sick Children

Data source: The Hospital for Sick Children

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada